UA94477C2 - Воспроизведенные сурфактанты, которые имеют улучшенные свойства - Google Patents

Воспроизведенные сурфактанты, которые имеют улучшенные свойства

Info

Publication number
UA94477C2
UA94477C2 UAA200903082A UAA200903082A UA94477C2 UA 94477 C2 UA94477 C2 UA 94477C2 UA A200903082 A UAA200903082 A UA A200903082A UA A200903082 A UAA200903082 A UA A200903082A UA 94477 C2 UA94477 C2 UA 94477C2
Authority
UA
Ukraine
Prior art keywords
improved properties
reconstituted surfactants
reconstituted
directed
surfactants
Prior art date
Application number
UAA200903082A
Other languages
English (en)
Ukrainian (uk)
Inventor
Ян Йоганссон
Торе Курстедт
Бенгт Робертсон
Original Assignee
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39079026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA94477(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. filed Critical КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Publication of UA94477C2 publication Critical patent/UA94477C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

Abstract

Заявленное изобретение относится к воспроизведенному сурфактанту, который содержит липидный носитель, полипептидный аналог белка природного ПАВ SP-C, и полипептидный аналог белка природного ПАВ SP-B, также к его фармацевтической композиции и его применения для лечения или профилактики респираторного дистресс-синдрома и других респираторных расстройств.
UAA200903082A 2006-10-13 2007-09-28 Воспроизведенные сурфактанты, которые имеют улучшенные свойства UA94477C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06021521 2006-10-13

Publications (1)

Publication Number Publication Date
UA94477C2 true UA94477C2 (ru) 2011-05-10

Family

ID=39079026

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200903082A UA94477C2 (ru) 2006-10-13 2007-09-28 Воспроизведенные сурфактанты, которые имеют улучшенные свойства

Country Status (36)

Country Link
US (2) US8183210B2 (ru)
EP (1) EP2078038B1 (ru)
JP (2) JP5405307B2 (ru)
KR (1) KR101328851B1 (ru)
CN (2) CN103169947B (ru)
AR (2) AR063263A1 (ru)
AU (1) AU2007306075B2 (ru)
BR (1) BRPI0715317B1 (ru)
CA (1) CA2666344C (ru)
CL (1) CL2007002931A1 (ru)
CO (1) CO6400235A2 (ru)
CY (1) CY1114716T1 (ru)
DK (1) DK2078038T3 (ru)
EA (1) EA015802B1 (ru)
ES (1) ES2438727T3 (ru)
GE (1) GEP20125531B (ru)
HK (2) HK1134497A1 (ru)
HR (1) HRP20140052T1 (ru)
IL (1) IL198075A (ru)
JO (1) JO2963B1 (ru)
MA (1) MA31062B1 (ru)
ME (2) ME02326B (ru)
MX (1) MX343064B (ru)
MY (1) MY148127A (ru)
NO (1) NO342038B1 (ru)
NZ (1) NZ576189A (ru)
PE (1) PE20081184A1 (ru)
PL (1) PL2078038T3 (ru)
PT (1) PT2078038E (ru)
RS (1) RS53172B (ru)
SI (1) SI2078038T1 (ru)
TN (1) TN2009000099A1 (ru)
TW (1) TWI388333B (ru)
UA (1) UA94477C2 (ru)
WO (1) WO2008044109A1 (ru)
ZA (1) ZA200902481B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2049554A4 (en) 2006-07-20 2011-06-29 Univ Rochester Medical Ct SYNTHETIC PULMONARY SURFACTANT AND USE THEREOF
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8399406B2 (en) * 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
CN101948526B (zh) * 2010-09-02 2012-12-05 华东理工大学 一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法
EP2812018B1 (en) 2012-02-09 2018-12-05 University Of Rochester Novel sp-b&sp-c peptides, synthetic lung surfactants, and use thereof
US20130303726A1 (en) 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
BR112015009486B1 (pt) * 2012-11-21 2022-06-14 Chiesi Farmaceutici S.P.A Surfactante reconstituído, formulação farmacêutica, kit e uso de surfactante reconstituído
US10717777B2 (en) 2015-12-17 2020-07-21 The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Synthetic lung surfactant with enhanced stability and effectiveness
CA3016810C (en) 2016-03-07 2024-04-02 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for administering ppar.gamma. agonists, surfactant peptides and phospholipids
MX2019001854A (es) 2016-08-24 2019-11-11 Chiesi Farm Spa Formulacion farmaceutica estable que comprende una composicion de tensioactivo pulmonar reconstituido.
WO2021151853A1 (en) 2020-01-28 2021-08-05 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08512056A (ja) * 1993-06-30 1996-12-17 ジェネンテク・インコーポレイテッド リポソームの製造法
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
US7065342B1 (en) * 1999-11-23 2006-06-20 Gofigure, L.L.C. System and mobile cellular telephone device for playing recorded music
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
EP2049554A4 (en) * 2006-07-20 2011-06-29 Univ Rochester Medical Ct SYNTHETIC PULMONARY SURFACTANT AND USE THEREOF
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides

Also Published As

Publication number Publication date
TN2009000099A1 (en) 2010-08-19
TW200824705A (en) 2008-06-16
US9238058B2 (en) 2016-01-19
GEP20125531B (en) 2012-05-25
JP2013241449A (ja) 2013-12-05
US20130079275A1 (en) 2013-03-28
US8183210B2 (en) 2012-05-22
JP2010505937A (ja) 2010-02-25
DK2078038T3 (da) 2013-12-02
KR101328851B1 (ko) 2013-11-14
NO20091441L (no) 2009-06-23
IL198075A (en) 2016-04-21
NZ576189A (en) 2011-09-30
MX343064B (es) 2016-10-24
PT2078038E (pt) 2013-12-12
AR063263A1 (es) 2009-01-14
CA2666344A1 (en) 2008-04-17
RS53172B (en) 2014-06-30
WO2008044109A1 (en) 2008-04-17
SI2078038T1 (sl) 2014-02-28
TWI388333B (zh) 2013-03-11
US20100004173A1 (en) 2010-01-07
AR113422A2 (es) 2020-04-29
PL2078038T3 (pl) 2014-05-30
KR20090083892A (ko) 2009-08-04
HK1134497A1 (en) 2010-04-30
EP2078038A1 (en) 2009-07-15
BRPI0715317A2 (pt) 2013-07-09
AU2007306075A1 (en) 2008-04-17
BRPI0715317B1 (pt) 2021-10-05
EA015802B1 (ru) 2011-12-30
CL2007002931A1 (es) 2008-03-24
ZA200902481B (en) 2010-07-28
CA2666344C (en) 2017-04-18
HRP20140052T1 (hr) 2014-02-28
AU2007306075B2 (en) 2012-08-09
CN103169947B (zh) 2014-10-29
CO6400235A2 (es) 2012-03-15
MX2009003638A (es) 2009-04-22
EP2078038B1 (en) 2013-11-20
CN101522711B (zh) 2013-11-13
CN101522711A (zh) 2009-09-02
CN103169947A (zh) 2013-06-26
MY148127A (en) 2013-02-28
NO342038B1 (no) 2018-03-19
MA31062B1 (fr) 2010-01-04
EA200900373A1 (ru) 2009-10-30
IL198075A0 (en) 2011-08-01
PE20081184A1 (es) 2008-09-26
ES2438727T3 (es) 2014-01-20
ME02326B (me) 2016-06-20
JO2963B1 (en) 2016-03-15
JP5405307B2 (ja) 2014-02-05
MEP12109A (en) 2011-12-20
CY1114716T1 (el) 2016-10-05
HK1185274A1 (en) 2014-02-14

Similar Documents

Publication Publication Date Title
TN2009000099A1 (en) Reconstituted surfactants having improved properties
MX2009012675A (es) Tensioactivos reconstituidos que tienen propiedades mejoradas.
UA103526C2 (ru) Воспроизведенный сурфактант, который содержит аналоги белков естественных сурфактантов sp-b и sp-c
IN2015DN02553A (ru)
EP3533461A3 (en) Prame derived peptides and immunogenic compositions comprising these
WO2009035540A3 (en) Analogues of exendin-4 and exendin-3
MX2010002716A (es) Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago.
WO2009010968A3 (en) Disease treatment via antimicrobial peptides or their inhibitors
MX2010001543A (es) Peptidos de surfactante pulmonar sintetico.
TW200740456A (en) GLP-1 pharmaceutical compositions
AU2003251728A8 (en) Placental growth factor as a target for the treatment of osteoporosis
RS20170169A1 (sr) Poboljšana rekonstituisana kompozicija sufraktanta koja sadrži analoge sufraktanta proteina b (sp-b) i surfaktanta proteina c (sp-c)
UA96003C2 (en) PHARMACEUTICAL COMPOSITION [Aib8,35]hGLP-1(7-36)NH2